Manaka Sato

7PUBLICATIONS
23CO-AUTHORS
Traditional Chinese medicine and treatmentsPharmacogenomicsNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 07, 2025
Correction to: The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan.

Toshihiko Aranishi, Ataru Igarashi, Kazuo Hara

|Dec 21, 2024
The Long-Term Cost-Effectiveness of Tirzepatide 5 mg versus Dulaglutide 0.75 mg for the Treatment of People with Type 2 Diabetes in Japan.

Toshihiko Aranishi, Ataru Igarashi, Kazuo Hara

|May 17, 2024
Therapy-Related Satisfaction and Quality of Life for Japanese People with Diabetes Using Rapid-Acting Insulin Analogs: A Web-Based Survey.

Hitoshi Ishii, Yasutaka Maeda, Manaka Sato

|Oct 19, 2023
Prevalence of Metabolic Syndrome in Patients with Type 2 Diabetes in Japan: A Retrospective Cross-Sectional Study.

Yasushi Ishigaki, Tetsuaki Hirase, Swathi Pathadka

Pageof 2